Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Flu activity
View:
Post by hmmmmmmmm on Oct 24, 2022 1:34pm

Flu activity

The CDC has flu activity as "High" in NY where Spectral has 2 Tigris sites
Tennessee: "High", 2 sites
Washington DC: "Very High" 1 site
Louisiana: "High" 1 site

The map is turning red for a flu season like we haven't seen in a long time. Spectral has at least 6 Tigris sites that are already in High to Very High activity. And Covid is no longer a valid excuse for the lack testing.

Spectral needs to deliver a substantial increase in patients enrolled.
If they are not able to at least reach their "Worst Case Scenario" of .5 patients per clinic per month or 7 patients per month as promised- it will be clear that their process is the issue.

At 1 million dollars a month we need to see results from management. If they can't deliver over these next 3 months it will be beyond clear that we need a change at the top. Running trials can be difficult, but that's the job at hand. Time for Seto to finally deliver on one of the promises he's made over the last two years.
Comment by mercedesman on Oct 24, 2022 1:55pm
You are not wrong. This is on JK as much as it is on CS. It's time to make hay while the sun shines - i.e it's time to ramp up enrolment boyz ! MM
Comment by hmmmmmmmm on Oct 24, 2022 2:38pm
Seto invested in a fancy new CFO instead of 2 Clinical Trial Managers to replace Debra Foster. He told us in September of last year that he'd deliver 60 new patients by that years end. He gave himself millions in "Incentivising" shares! He needs to own this one way or the other.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities